Thus, ClpP operates within a broader proteostasis network involving HSP60 and LONP1 and is regulated by oncogenic signaling pathways such as c-Myc, particularly in treatment-resistant PCa subtypes (Figure 9). The gene discussed is LONP1; the disease is posterior cortical atrophy.